Risankizumab-Aggravated Crusted Scabies in a Patient with Down Syndrome
Sign Up to like & getrecommendations! Published in 2020 at "Dermatology and Therapy"
DOI: 10.1007/s13555-020-00386-8
Abstract: Risankizumab, an interleukin (IL)-23 antagonist, is a highly effective treatment for moderate to severe psoriasis. Crusted scabies (CS) is a rare and severe form of scabies, occurring mainly in immunosuppressed patients and/or neurologically or mentally… read more here.
Keywords: aggravated crusted; patient syndrome; scabies patient; crusted scabies ... See more keywords